Servier is an international pharmaceutical company governed by a non-profit foundation, with its headquarters in France (Suresnes). With a strong international presence in 149 countries and a turnover of 4.2 billion euros in 2018, Servier employs 21,600 people worldwide. Entirely independent, the Group reinvests 25% of its turnover (excluding generic drugs) in research and development and uses all its profits for development. Corporate growth is driven by Servier’s constant search for innovation in five areas of expertise: cardiovascular, immuno-inflammatory and neuropsychiatric diseases, cancers and diabetes, as well as by its activities in high-quality generic drugs.
With our continued strategic partnership with Acrotec, and the purchase of Shire’s Oncology business in August 2019, Servier Canada’s Oncology business unit is looking to hire a Medical Science Liaison Hematology & Oncology responsible for Western Canada. Based in Vancouver and reporting to the Scientific and Medical Head, Oncology, the incumbent will support a number of medications, both marketed and in development.
Anticipated Start Date: September 2020
The Medical Science Liaison (MSL) is responsible for developing and fostering professional relationships, with key opinion leaders (KOLs) and decision makers. The Medical Science Liaison (MSL) is particularly responsible for identifying experts in patient care gaps, treatment trends and emerging clinical science in related therapeutic areas and collaborating with them to ensure that Servier can develop pertinent strategies adapted to the needs and the reality of Canadian patients and health care professionals. In addition, the MSL is responsible for providing field-based support for local scientific data discussions and for collecting input and managing activities based on peer-to-peer relationships with national, regional and local KOLs. Specifically this individual is responsible for:
- Discussing the current state of diseases with doctors and KOLs, and providing them with a fair and balanced scientific exchange and medical information
- Sharing and discussing scientific information data with healthcare professionals to ensure quality and accuracy of medical and scientific information for new treatment options;
- Collaborating with and supporting KOLs in the development of continuing medical education events (CMEs) and medical projects;
- Contributing to the identification of KOLs and decision makers in the related therapeutic areas;
- Keeping abreast of key care gaps, treatment trends and emerging clinical science and ensuring that this information is shared with the appropriate departments;
- Acting as a scientific liaison between internal departments and external medical leaders and KOLs;
- Actively supporting medical and scientific meetings and/or congresses;
- Building and maintaining an in-depth knowledge of diseases, products and therapies;
- Participating in the implementation of trial and Phase IV program strategies in Canada;
- Contributing to the identification of clinical research study sites;
- Supporting a number of Servier internal departments with scientific expertise and understanding of the therapeutic area within Canada;
- Motivating Servier colleagues by demonstrating a spirit of support and collaboration;
- Furthering the positive image of Servier in Oncology.
- Candidates must hold a university graduate degree in Science (Dr., MD, D. Pharm, and M.Sc. Pharm).
- Prior experience in a similar role is required, as is experience in the field of Hematology/Oncology;
- In-depth understanding of the processes and procedures involved in drug development, including commercialization and regulatory aspects;
- Ability to develop and maintain credible relationships with health care professionals;
- Strong interpersonal and teaming skills,
- Excellent communication and presentation skills;
- Strong business acumen;
- High degree of professionalism and integrity;
- Available to travel and attend scientific congresses;
- Ability to communicate well in English, oral and written (bilingualism would be an asset).